Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

OPC-31260: potential utility in cirrhosis patients with impaired water handling

Dec. 30, 1998

Tobishi's pollen extract improves bladder dysfunction, nonbacterial prostatitis in rats

Dec. 21, 1998

FDA clears first and only once-daily treatment for overactive bladder

Dec. 21, 1998

New agents for micturition disorders discovered at Kyowa Hakko

Dec. 16, 1998

Vanguard drops hyperphosphatemia Rx from development pipeline

Dec. 16, 1998

Fujisawa describes potential new agent for treating BPH

Dec. 8, 1998

Pharmacokinetic studies support chronic dosing of FK-143

Dec. 3, 1998

Health Canada approves first new incontinence medication in over a decade

Dec. 3, 1998

Tamsulosin improves signs and symptoms of BPH in phase III study

Dec. 1, 1998

Pfizer claims new series for BPH with selective prostatic alpha1-adrenoceptor-antagonist effects

Dec. 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...